Eli Lilly and Company
(trifluoromethyl)pyrimidine-2-amine compounds

Last updated:

Abstract:

The present invention provides a compound of Formula I: ##STR00001## wherein R.sup.1 is hydrogen or methyl; and R.sup.2 is: ##STR00002## or a pharmaceutically acceptable salt thereof, useful for treating pain, including chronic pain, chronic lower back pain, diabetic peripheral neuropathic pain, and osteoarthritis pain.

Status:
Grant
Type:

Utility

Filling date:

30 Apr 2021

Issue date:

16 Aug 2022